Celltrion Pharm, Inc. (KOSDAQ:068760)
South Korea flag South Korea · Delayed Price · Currency is KRW
45,850
+850 (1.89%)
Aug 11, 2026, 1:50 PM KST

Celltrion Pharm Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Net Income
26,02620,9408,602-9,38915,715-21,106
Depreciation & Amortization
13,91113,47013,02312,71212,23412,069
Loss (Gain) From Sale of Assets
25.6425.64458.613.36--
Asset Writedown & Restructuring Costs
--305.63,902--
Stock-Based Compensation
767.16795.11628.92475.5213.9103.78
Provision & Write-off of Bad Debts
-465.73322.6277.23232.87-425.09-30.41
Other Operating Activities
5,8376,89912,92515,433-6,85019,011
Change in Accounts Receivable
-21,897-1,674-5,925-27,555-40,952-37,217
Change in Inventory
-29,675-25,9794,06520,2778,545-7,984
Change in Accounts Payable
25,35614,803-5,567-792.2403.1710,527
Change in Other Net Operating Assets
8,5506,643-938.61-988.34952.68-1,583
Operating Cash Flow
28,43536,24627,85514,313-10,163-26,209
Operating Cash Flow Growth
-41.05%30.13%94.62%---

Investing Activities

Fiscal Year
TTMFY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Capital Expenditures
-30,616-41,978-30,488-7,207-1,079-2,085
Sale of Property, Plant & Equipment
4.734.7335.496.11-0.35
Sale (Purchase) of Intangibles
-1,985-2,277-1,558-677.98-230.32-2,442
Investment in Securities
-8,200-632.26-2,568315--
Other Investing Activities
143.431.84108.43144.31-11.94216.33
Investing Cash Flow
-40,653-44,880-34,470-7,331-1,0122,369

Financing Activities

Fiscal Year
TTMFY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Short-Term Debt Issued
-25,70243,11874,38075,01552,700
Long-Term Debt Issued
-32,41117,978--10,000
Total Debt Issued
48,61258,11361,09674,38075,01562,700
Short-Term Debt Repaid
--13,662-33,011-64,799-35,371-39,244
Long-Term Debt Repaid
--14,199-14,135-6,875-34,000-
Total Debt Repaid
-24,872-27,861-47,146-71,674-69,371-39,244
Net Debt Issued (Repaid)
23,74030,25213,9502,7065,64423,455
Issuance of Common Stock
245.53271.84255.8648.081,109947.09
Repurchase of Common Stock
-1,104-1,104--1,031-101.58-49.04
Other Financing Activities
-5,834-5,798-5,949-5,832-5.18-31.83
Financing Cash Flow
17,04823,6218,257-3,5096,64624,322

Net Cash Flow

Fiscal Year
TTMFY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Foreign Exchange Rate Adjustments
3.06-3.734.316.77-28.0211.49
Miscellaneous Cash Flow Adjustments
-0----0-0
Net Cash Flow
4,83314,9841,6463,480-4,557493.08

Free Cash Flow

Fiscal Year
TTMFY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Free Cash Flow
-2,181-5,731-2,6337,106-11,242-28,294
Free Cash Flow Growth
------
Free Cash Flow Margin
-0.79%-2.45%-1.52%4.84%-8.28%-27.00%
Free Cash Flow Per Share
-48.89-128.59-59.18160.36-257.21-763.96
Levered Free Cash Flow
-20,097-20,870-4,13821,654-25,424-17,585
Unlevered Free Cash Flow
-17,194-18,006-860.5225,382-22,002-12,298

Additional Metrics

Fiscal Year
TTMFY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash Interest Paid
5,8305,8355,9485,8285,4846,024
Cash Income Tax Paid
707.47526.18-2,616-254.441,171-89.76
Change in Working Capital
-17,666-6,206-8,366-9,058-31,051-36,256